yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q33797609-135F3D30-6C61-4C8D-8BB9-8D3AFFFC0AD7
Q33797609-135F3D30-6C61-4C8D-8BB9-8D3AFFFC0AD7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33797609-135F3D30-6C61-4C8D-8BB9-8D3AFFFC0AD7
Fondaparinux and acute coronary syndromes: update on the OASIS 5-6 studies.
P2860
Q33797609-135F3D30-6C61-4C8D-8BB9-8D3AFFFC0AD7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33797609-135F3D30-6C61-4C8D-8BB9-8D3AFFFC0AD7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9e59f1f27cd4a107754c86cd9815f4eec890c8e7
P2860
Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.